These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inverse relationship of baseline body temperature and outcome between ischemic stroke patients treated and not treated with thrombolysis: the Bergen stroke study. Naess H; Idicula T; Lagallo N; Brogger J; Waje-Andreassen U; Thomassen L Acta Neurol Scand; 2010 Dec; 122(6):414-7. PubMed ID: 20199522 [TBL] [Abstract][Full Text] [Related]
3. Missing the point (estimate)? Confidence intervals for the number needed to treat. Barrowman NJ CMAJ; 2002 Jun; 166(13):1676-7. PubMed ID: 12126323 [No Abstract] [Full Text] [Related]
4. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus. Levi CR; ; ; Med J Aust; 2004 Jun; 180(12):634-6. PubMed ID: 15200362 [TBL] [Abstract][Full Text] [Related]
5. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T; Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715 [TBL] [Abstract][Full Text] [Related]
6. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study]. Di Pasquale G Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744 [No Abstract] [Full Text] [Related]
7. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134 [TBL] [Abstract][Full Text] [Related]
8. Using tPA for acute stroke in a rural setting. Gross H; Hall C; Switzer JA; Adams RJ; Wang S; Hess DC; Nichols FT; Pardue C Neurology; 2007 May; 68(22):1957-8; author reply 1958. PubMed ID: 17536059 [No Abstract] [Full Text] [Related]
9. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA; Starr JA Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [TBL] [Abstract][Full Text] [Related]
10. Emergency physician survey: recombinant tissue plasminogen activator for stroke. Mann J Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689 [No Abstract] [Full Text] [Related]
11. Does intravenous rtPA benefit patients in the absence of CT angiographically visible intracranial occlusion? Sylaja PN; Dzialowski I; Puetz V; Eliasziw M; Hill MD; Krol A; O'Reilly C; Demchuk AM Neurol India; 2009; 57(6):739-43. PubMed ID: 20139502 [TBL] [Abstract][Full Text] [Related]
12. Predictors of good clinical outcome in acute stroke patients treated with intravenous thrombolysis. Saňák D; Herzig R; Zapletalová J; Horák D; Král M; Skoloudík D; Bártková A; Veverka T; Heřman M; Kaňovský P Acta Neurol Scand; 2011 May; 123(5):339-44. PubMed ID: 20597864 [TBL] [Abstract][Full Text] [Related]
13. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network. Dowlatshahi D; Hakim A; Fang J; Sharma M; Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119 [TBL] [Abstract][Full Text] [Related]
14. Litigation regarding tPA and stroke. Pilcher CA Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673 [No Abstract] [Full Text] [Related]
15. A hundred (and one) graphs tell only part of the story. Silbergleit R Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418 [No Abstract] [Full Text] [Related]
16. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset? Alexandrov AV Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558 [No Abstract] [Full Text] [Related]